What is Legal Insider Trading? How do I use this site?
Learn More ›
Login/Signup
Top Companies
Form Screener
Random Insider
Random Company
Sectors
FAQ
Feedback
Blog
Pricing
Aclaris Therapeutics, Inc. (ACRS)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Diagnostics & Research
Date
Insider
Company
Owned Shares
Shares Traded
Price
Net Total
BUY
17 Mar 2023
Manion Douglas J.
Pres and CEO, Director, Officer
Aclaris Therapeutics, Inc.
(ACRS)
12,800
+96%
6,300
$7.86
$49,532.49
SELL
1 Mar 2023
Balthaser Kevin
Chief Financial Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
5,256
-26%
1,894
$12.45
$23,578.52
SELL
1 Mar 2023
Monahan Joseph
Chief Scientific Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
147,724
-17%
30,837
$12.51
$385,638.88
SELL
1 Mar 2023
Walker Neal
Director
Aclaris Therapeutics, Inc.
(ACRS)
1,273,202
-4%
59,240
$12.50
$740,658.20
SELL
15 Feb 2023
Monahan Joseph
Chief Scientific Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
91,386
-5%
5,000
$13.06
$65,310.50
SELL
8 Feb 2023
Loerop James
Chief Business Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
6,983
-37%
4,267
$13.89
$59,272.47
SELL
1 Feb 2023
Walker Neal
Director
Aclaris Therapeutics, Inc.
(ACRS)
1,179,684
-2%
30,000
$16.66
$499,922.78
SELL
3 Jan 2023
Walker Neal
Director
Aclaris Therapeutics, Inc.
(ACRS)
1,205,763
-3%
40,000
$15.11
$604,555.75
SELL
15 Dec 2022
Monahan Joseph
Chief Scientific Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
96,386
-4%
5,000
$15.88
$79,411.50
SELL
10 Nov 2022
SCHIFF ANDREW N
Director
Aclaris Therapeutics, Inc.
(ACRS)
434,455
-11%
53,926
$17.05
$919,589.25
SELL
24 Oct 2022
SCHIFF ANDREW N
Director
Aclaris Therapeutics, Inc.
(ACRS)
488,381
-7%
41,174
$17.01
$700,355.00
SELL
17 Oct 2022
Monahan Joseph
Chief Scientific Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
101,386
-4%
5,000
$15.98
$79,907.50
SELL
17 Oct 2022
SCHIFF ANDREW N
Director
Aclaris Therapeutics, Inc.
(ACRS)
529,555
-8%
52,037
$16.57
$862,109.10
SELL
7 Oct 2022
SCHIFF ANDREW N
Director
Aclaris Therapeutics, Inc.
(ACRS)
581,592
-1%
7,324
$16.16
$118,349.24
SELL
4 Oct 2022
SCHIFF ANDREW N
Director
Aclaris Therapeutics, Inc.
(ACRS)
588,916
-7%
45,539
$16.45
$749,002.06
SELL
17 Jun 2022
SCHIFF ANDREW N
Director
Aclaris Therapeutics, Inc.
(ACRS)
0
-100%
19,565
$15.14
$296,268.88
SELL
21 Apr 2022
Walker Neal
President and CEO, Director, Officer
Aclaris Therapeutics, Inc.
(ACRS)
1,245,763
-5%
70,000
$15.15
$1,060,701.00
SELL
18 Apr 2022
Monahan Joseph
Chief Scientific Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
106,386
-21%
30,000
$16.28
$488,298.00
SELL
11 Mar 2022
Walker Neal
President and CEO, Director, Officer
Aclaris Therapeutics, Inc.
(ACRS)
1,315,763
-4%
56,303
$15.91
$896,045.30
SELL
10 Mar 2022
Monahan Joseph
Chief Scientific Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
136,386
-16%
27,165
$15.71
$426,802.90
SELL
10 Mar 2022
Ruffo Frank
Chief Financial Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
201,883
-5%
12,823
$15.55
$199,334.81
SELL
9 Feb 2022
Walker Neal
President and CEO, Director, Officer
Aclaris Therapeutics, Inc.
(ACRS)
1,239,387
-0%
3,595
$12.66
$45,513.42
SELL
9 Feb 2022
Monahan Joseph
Chief Scientific Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
87,301
-0%
383
$12.68
$4,857.13
SELL
9 Feb 2022
Ruffo Frank
Chief Financial Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
172,359
-0%
1,388
$12.66
$17,568.47
SELL
13 Jul 2021
Gordon David N.
Chief Medical Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
147,447
-1%
2,631
$16.98
$44,674.65
SELL
3 Jun 2021
Ali-Jackson Kamil
Chief Legal Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
122,196
-7%
9,492
$21.96
$208,420.60
SELL
1 Jun 2021
Walker Neal
President and CEO, Director, Officer
Aclaris Therapeutics, Inc.
(ACRS)
1,237,699
-2%
33,260
$21.64
$719,734.94
SELL
1 Jun 2021
Monahan Joseph
Chief Scientific Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
88,892
-19%
21,790
$21.64
$471,436.62
SELL
1 Jun 2021
Ali-Jackson Kamil
Chief Legal Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
149,324
-23%
45,119
$22.10
$996,963.06
SELL
1 Jun 2021
Gordon David N.
Chief Medical Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
150,878
-25%
51,914
$22.01
$1,142,374.60
SELL
1 Jun 2021
Ruffo Frank
Chief Financial Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
172,322
-8%
15,037
$21.64
$325,382.62
SELL
6 May 2021
Ali-Jackson Kamil
Chief Legal Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
145,718
-12%
20,416
$23.45
$478,844.94
SELL
3 May 2021
Ali-Jackson Kamil
Chief Legal Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
144,116
-23%
45,000
$24.08
$1,083,718.50
SELL
22 Apr 2021
Walker Neal
President and CEO, Director, Officer
Aclaris Therapeutics, Inc.
(ACRS)
1,192,427
-2%
30,000
$26.84
$805,239.00
SELL
22 Apr 2021
Ruffo Frank
Chief Financial Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
151,820
-36%
87,339
$26.45
$2,310,106.20
SELL
27 Jun 2019
Flynn James E
10% Owner
Aclaris Therapeutics, Inc.
(ACRS)
964,101
-42%
699,475
$2.69
$1,882,077.40
SELL
26 Jun 2019
Flynn James E
10% Owner
Aclaris Therapeutics, Inc.
(ACRS)
1,072,775
-0%
1,704
$4.50
$7,670.56
SELL
21 Jun 2019
Flynn James E
10% Owner
Aclaris Therapeutics, Inc.
(ACRS)
1,073,127
-29%
454,261
$4.59
$2,085,238.10
SELL
9 May 2019
Flynn James E
10% Owner
Aclaris Therapeutics, Inc.
(ACRS)
4,111,747
-13%
614,710
$6.13
$3,765,521.50
BUY
22 Oct 2018
Mehra Anand
Director
Aclaris Therapeutics, Inc.
(ACRS)
1,911,573
+24%
372,093
$10.75
$3,999,999.80
BUY
4 Oct 2018
Tullman Stephen A.
Director
Aclaris Therapeutics, Inc.
(ACRS)
177,457
+4%
7,100
$14.00
$99,370.18
BUY
23 Aug 2018
Tullman Stephen A.
Director
Aclaris Therapeutics, Inc.
(ACRS)
170,357
+4%
6,600
$15.00
$98,984.82
BUY
15 Aug 2018
Tullman Stephen A.
Director
Aclaris Therapeutics, Inc.
(ACRS)
163,757
+3%
6,250
$15.97
$99,812.50
SELL
11 Jun 2018
Ali-Jackson Kamil
Chief Legal Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
77,636
-6%
5,000
$20.00
$100,000.00
SELL
18 May 2018
Ali-Jackson Kamil
Chief Legal Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
82,636
-10%
10,000
$20.00
$200,000.00
BUY
16 May 2018
Powell Andrew Kenneth William
Director
Aclaris Therapeutics, Inc.
(ACRS)
500
+100%
500
$19.12
$9,560.00
BUY
7 May 2018
Ruffo Frank
Chief Financial Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
156,865
+0%
1,250
$18.22
$22,775.00
BUY
6 Apr 2018
Tullman Stephen A.
Director
Aclaris Therapeutics, Inc.
(ACRS)
157,507
+20%
26,700
$16.54
$441,618.03
BUY
6 Apr 2018
Ruffo Frank
Chief Financial Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
155,615
+0%
1,250
$16.59
$20,737.50
BUY
6 Apr 2018
Molineaux Christopher P.
Director
Aclaris Therapeutics, Inc.
(ACRS)
7,682
+42%
2,300
$16.52
$37,996.00
BUY
5 Apr 2018
Walker Neal
President and CEO, Director, Officer
Aclaris Therapeutics, Inc.
(ACRS)
897,184
+1%
10,000
$16.75
$167,500.00
BUY
16 Aug 2017
SCHIFF ANDREW N
Director
Aclaris Therapeutics, Inc.
(ACRS)
634,455
+20%
108,601
$23.02
$2,499,995.00
SELL
28 Feb 2017
VIVO VENTURES VII, LLC
10% Owner
Aclaris Therapeutics, Inc.
(ACRS)
2,797,597
-13%
425,000
$30.82
$13,098,000.00
SELL
10 Jan 2017
Mehra Anand
Director
Aclaris Therapeutics, Inc.
(ACRS)
1,539,480
-32%
750,000
$28.25
$21,188,326.00
SELL
16 Nov 2016
VIVO VENTURES VII, LLC
10% Owner
Aclaris Therapeutics, Inc.
(ACRS)
3,213,532
-22%
907,828
$23.03
$20,908,050.00
SELL
26 Oct 2016
Ali-Jackson Kamil
Chief Legal Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
75,957
-4%
3,912
$21.83
$85,398.96
SELL
26 Oct 2016
FMR LLC
10% Owner, See Remark 1
Aclaris Therapeutics, Inc.
(ACRS)
2,571,454
-0%
3,750
$21.94
$82,259.50
SELL
26 Sep 2016
Ali-Jackson Kamil
Chief Legal Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
75,957
-2%
1,841
$24.66
$45,399.06
SELL
15 Sep 2016
RA CAPITAL MANAGEMENT, LLC
10% Owner
Aclaris Therapeutics, Inc.
(ACRS)
2,125,769
-19%
525,550
$24.19
$12,713,502.00
SELL
26 Aug 2016
Ali-Jackson Kamil
Chief Legal Officer, Officer
Aclaris Therapeutics, Inc.
(ACRS)
20,289
-15%
3,738
$20.35
$76,068.31
BUY
22 Feb 2016
RA CAPITAL MANAGEMENT, LLC
10% Owner
Aclaris Therapeutics, Inc.
(ACRS)
2,627,719
+1%
39,726
$17.15
$681,469.90
BUY
15 Jan 2016
RA CAPITAL MANAGEMENT, LLC
10% Owner
Aclaris Therapeutics, Inc.
(ACRS)
2,587,993
+0%
7,803
$19.87
$155,072.47
BUY
11 Jan 2016
RA CAPITAL MANAGEMENT, LLC
10% Owner
Aclaris Therapeutics, Inc.
(ACRS)
2,580,190
+0%
15,637
$19.10
$298,737.75
Home